Alzheimer’s disease biological PET staging using plasma p217+tau
Alzheimer’s disease biological PET staging using plasma p217+tau
About this item
Full title
Author / Creator
Feizpour, Azadeh , Doré, Vincent , Krishnadas, Natasha , Bourgeat, Pierrick , Doecke, James D. , Saad, Ziad S. , Triana-Baltzer, Gallen , Laws, Simon M. , Shishegar, Rosita , Huang, Kun , Fowler, Christopher , Ward, Larry , Masters, Colin L. , Fripp, Jurgen , Kolb, Hartmuth C. , Villemagne, Victor L. and Rowe, Christopher C.
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Background
Plasma phospho-tau biomarkers, such as p217+tau, excel at identifying Alzheimer’s disease (AD) neuropathology. However, their ability to substitute for tau PET to identify AD biological stage is unclear.
Methods
Participants included 248 cognitively unimpaired (CU) and 227 cognitively impaired (CI) individuals, with Janssen plas...
Alternative Titles
Full title
Alzheimer’s disease biological PET staging using plasma p217+tau
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5524eda9126c4dd39c4b9f4bdbda2ece
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5524eda9126c4dd39c4b9f4bdbda2ece
Other Identifiers
ISSN
2730-664X
E-ISSN
2730-664X
DOI
10.1038/s43856-025-00768-z
